Daisuke Kudo

Daisuke Kudo

Auto-generated profile, based on publicly available information

Daisuke Kudo

SETOLAS Holdings Inc., Sakaide 762-0012, Kagawa, Japan

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2023 in Nanomaterials
Verified
Journal Article
Open access
PDF file
KOKentaro Okamoto
Kentaro Okamoto
DKDaisuke Kudo
Daisuke Kudo
PDPhuong Nguyen Duy Dao
Phuong Nguyen Duy Dao
YIYoshihito Iwamoto
Yoshihito Iwamoto
KWKoji Watanabe
Koji Watanabe
RYRyota Yamasaki
Ryota Yamasaki
Although various caries-preventive agents have been developed, dental caries is still a leading global disease, mostly caused by biological factors such as mutans streptococci. Magnesium hydroxide nanoparticles have been reported to exhibit antibacterial effects; however, they are rarely used in oral care practical applications. In this study, we examined the inhibitory effect of magnesium hydroxide nanoparticles on biofilm formation by Streptococcus mutans and Streptococcus sobrinus—two typical caries-causing bacteria. Three different sizes of magnesium hydroxide nanoparticles (NM80, NM300, and NM700) were studied, all of which inhibited biofilm formation. The results showed that the nanoparticles were important for the inhibitory effect, which was not influenced by pH or the presence of magnesium ions. We also determined that the inhibition process was mainly contact inhibition and that medium (NM300) and large (NM700) sizes were particularly effective in this regard. The findings of our study demonstrate the potential applications of magnesium hydroxide nanoparticles as caries-preventive agents.

27 April 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
AKAyaka Koga
Ayaka Koga
CTChuencheewit Thongsiri
Chuencheewit Thongsiri
DKDaisuke Kudo
Daisuke Kudo
PDPhuong Nguyen Duy Dao
Phuong Nguyen Duy Dao
YIYoshihito Iwamoto
Yoshihito Iwamoto
Wataru AriyoshiWataru Ariyoshi
Wataru Ariyoshi
In recent years, magnesium hydroxide has been widely studied due to its bioactivity and biocompatibility. The bactericidal effects of magnesium hydroxide nanoparticles on oral bacteria have also been reported. Therefore, in this study, we investigated the biological effects of magnesium hydroxide nanoparticles on inflammatory responses induced by periodontopathic bacteria. Macrophage-like cells, namely J774.1 cells, were treated with LPS derived from Aggregatibacter actinomycetemcomitans and two different sizes of magnesium hydroxide nanoparticles (NM80/NM300) to evaluate their effects on the inflammatory response. Statistical analysis was performed using an unresponsive Student’s t-test or one-way ANOVA followed by Tukey’s post hoc test. NM80 and NM300 inhibited the expression and secretion of IL-1β induced by LPS. Furthermore, IL-1β inhibition by NM80 was dependent on the downregulation of PI3K/Akt-mediated NF-κB activation and the phosphorylation of MAPK molecules such as JNK, ERK1/2, and p38 MAPK. By contrast, only the deactivation of the ERK1/2-mediated signaling cascade is involved in IL-1β suppression by NM300. Although the molecular mechanism involved varied with size, these results suggest that magnesium hydroxide nanoparticles have an anti-inflammatory effect against the etiologic factors of periodontopathic bacteria. These properties of magnesium hydroxide nanoparticles can be applied to dental materials.